HEART ARRHYTHMIA NON-INVASIVE TREATMENT DEVICE AND METHOD

    公开(公告)号:US20240269483A1

    公开(公告)日:2024-08-15

    申请号:US18628649

    申请日:2024-04-05

    申请人: EBAMed SA

    IPC分类号: A61N5/10 G16H40/60

    摘要: The present invention relates to a heart tissue ablation device comprising a charged particle emitting system 1, a control system 2 for instructing the accelerator and beamline when to create the beam and what its required properties should be, a patient positioning and verification system, an ultrasound cardiac imaging system 3 performed on the patient, able to track the target movement, a computer program to determine and record the safe motion margins, the treatment plans for one or more motion phases and a computer program to regulate the control system 2 to load the correct irradiation plan according to the motion phase and if the position of the target is inside of the position margin, the irradiation is enabled and if the position of the target is outside of the position margin, the irradiation is disabled.

    Systems and methods for CT imaging in image-guided radiotherapy

    公开(公告)号:US11911633B2

    公开(公告)日:2024-02-27

    申请号:US17814825

    申请日:2022-07-25

    IPC分类号: A61N5/10 A61B6/03

    摘要: The present disclosure relates to a radiation system. The system may include a treatment assembly, an imaging assembly, a first gantry, and a second gantry. The treatment assembly may include a first radiation source configured to deliver a treatment beam and have a treatment region. The first gantry may be configured to support the first radiation source. The imaging assembly may include a second radiation source and a radiation detector. The second radiation source may be configured to deliver an imaging beam and the radiation detector may be configured to detect at least a portion of the imaging beam. The imaging assembly may have an imaging region. The second gantry may be configured to support the second radiation source and the radiation detector, wherein the second radiation source is located within the second gantry. The treatment region and the imaging region at least partially overlap.